SHP Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Sell
2,293
-215
-9% -$218K 0.16% 43
2025
Q4
$2.7M Buy
+2,508
New +$2.4M 0.21% 36

Other funds holding LLY

SHP Wealth Management's LLY Position: Q1 2026 in Review

SHP Wealth Management reduced its Eli Lilly (LLY) stake by 8.6% in Q1 2026, selling an estimated $218K and leaving 2,293 shares worth $2.11M. The position accounts for 0.16% of the portfolio, ranked #43.

SHP Wealth Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.7M in Q4 2025. 4,364 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SHP Wealth Management held 2,293 shares of Eli Lilly worth $2.11M as of Q1 2026.
  • SHP Wealth Management sold 215 Eli Lilly shares in Q1 2026, an estimated $218K.
  • Eli Lilly made up 0.16% of SHP Wealth Management's portfolio in Q1 2026, its #43 holding.
  • SHP Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's Eli Lilly position peaked at $2.7M in Q4 2025.
  • 4,364 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.